Gene · 4633
Papers3,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In need of age-appropriate cardiac models: Impact of cell age on extracellular matrix therapy outcomes. | Aging Cell | 2023 | 37803909 | PubTator, text mining | PubMed |
| ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation. | Stem Cell Reports | 2023 | 37802074 | PubTator, text mining | PubMed |
| AAPM Medical Physics Practice Guideline 8.b: Linear accelerator performance tests. | J Appl Clin Med Phys | 2023 | 37793084 | PubTator, text mining | PubMed |
| Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels. | Front Physiol | 2023 | 37791351 | PubTator, text mining | PubMed |
| Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies. | Front Oncol | 2023 | 37790755 | PubTator, text mining | PubMed |
| Systematic identification of inter-chromosomal interaction networks supports the existence of RNA factories. | bioRxiv | 2023 | 37790381 | PubTator, text mining | PubMed |
| Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review. | Indian J Med Res | 2023 | 37787257 | PubTator, text mining | PubMed |
| Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment. | Front Bioeng Biotechnol | 2023 | 37771571 | PubTator, text mining | PubMed |
| Genetic Contribution to End-Stage Cardiomyopathy Requiring Heart Transplantation. | Circ Genom Precis Med | 2023 | 37767697 | PubTator, text mining | PubMed |
| Effects of 2,2'-Azobis(2-methylpropionamidine) Dihydrochloride Stress on the Gel Properties of Duck Myofibrillar Protein Isolate. | Molecules | 2023 | 37764497 | PubTator, text mining | PubMed |
| The Relationship between Changes in MYBPC3 Single-Nucleotide Polymorphism-Associated Metabolites and Elite Athletes' Adaptive Cardiac Function. | J Cardiovasc Dev Dis | 2023 | 37754829 | PubTator, text mining | PubMed |
| Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies. | Pharmgenomics Pers Med | 2023 | 37750083 | PubTator, text mining | PubMed |
| In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging. | Front Cardiovasc Med | 2023 | 37745108 | PubTator, text mining | PubMed |
| Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review. | Cancer Cell Int | 2023 | 37743502 | PubTator, text mining | PubMed |
| Seamless and non-destructive monitoring of extracellular microRNAs during cardiac differentiation from human pluripotent stem cells. | Stem Cell Reports | 2023 | 37738969 | PubTator, text mining | PubMed |
| A Rab-bit hole: Rab40 GTPases as new regulators of the actin cytoskeleton and cell migration. | Front Cell Dev Biol | 2023 | 37736498 | PubTator, text mining | PubMed |
| Indoloquinazoline alkaloids suppress angiogenesis and inhibit metastasis of melanoma cells. | Bioorg Chem | 2023 | 37734192 | PubTator, text mining | PubMed |
| [Clinical and genetic analysis of eight children with Primary hypertrophic cardiomyopathy]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37730219 | PubTator, text mining | PubMed |
| Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues. | Front Cardiovasc Med | 2023 | 37727305 | PubTator, text mining | PubMed |
| Accurate Classification of Non-ischemic Cardiomyopathy. | Curr Cardiol Rep | 2023 | 37721634 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4633/papers?page=12